Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Treated mice displayed myofibers nearly twice as large in cross-sectional area and demonstrated higher contractile strength, with reports of up to 70% greater force compared to untreated groups
The reconstituted solution requires refrigeration and careful handling to maintain potency
Long-term human safety outcomes remain unknown, and the compound should be treated as investigational only [4]
Start with a 0.5% concentration and increase as tolerated
This is one reason why the 0.9% formulation has remained the diluent of record for analytical chemistry as well as in-vivo research
PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations
US$ 29.38
US$ 25.79
US$ 21.24
US$ 26.82
US$ 23.72
US$ 29.48
US$ 28.18
US$ 26.39
